<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK3795" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK3795/" /><meta name="ncbi_pagename" content="Infantile-Onset Spinocerebellar Ataxia - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Infantile-Onset Spinocerebellar Ataxia - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Infantile-Onset Spinocerebellar Ataxia" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2018/04/19" /><meta name="citation_author" content="Tuula Lönnqvist" /><meta name="citation_pmid" content="20301746" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK3795/" /><meta name="citation_keywords" content="IOSCA, Mitochondrial DNA Depletion Syndrome 7" /><meta name="citation_keywords" content="IOSCA" /><meta name="citation_keywords" content="Mitochondrial DNA Depletion Syndrome 7" /><meta name="citation_keywords" content="Twinkle protein, mitochondrial" /><meta name="citation_keywords" content="TWNK" /><meta name="citation_keywords" content="Infantile-Onset Spinocerebellar Ataxia" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Infantile-Onset Spinocerebellar Ataxia" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Tuula Lönnqvist" /><meta name="DC.Date" content="2018/04/19" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK3795/" /><meta name="description" content="Infantile-onset spinocerebellar ataxia (IOSCA) is a severe, progressive neurodegenerative disorder characterized by normal development until age one year, followed by onset of ataxia, muscle hypotonia, loss of deep-tendon reflexes, and athetosis. Ophthalmoplegia and sensorineural deafness develop by age seven years. By adolescence, affected individuals are profoundly deaf and no longer ambulatory; sensory axonal neuropathy, optic atrophy, autonomic nervous system dysfunction, and hypergonadotropic hypogonadism in females become evident. Epilepsy can develop into a serious and often fatal encephalopathy: myoclonic jerks or focal clonic seizures that progress to epilepsia partialis continua followed by status epilepticus with loss of consciousness." /><meta name="og:title" content="Infantile-Onset Spinocerebellar Ataxia" /><meta name="og:type" content="book" /><meta name="og:description" content="Infantile-onset spinocerebellar ataxia (IOSCA) is a severe, progressive neurodegenerative disorder characterized by normal development until age one year, followed by onset of ataxia, muscle hypotonia, loss of deep-tendon reflexes, and athetosis. Ophthalmoplegia and sensorineural deafness develop by age seven years. By adolescence, affected individuals are profoundly deaf and no longer ambulatory; sensory axonal neuropathy, optic atrophy, autonomic nervous system dysfunction, and hypergonadotropic hypogonadism in females become evident. Epilepsy can develop into a serious and often fatal encephalopathy: myoclonic jerks or focal clonic seizures that progress to epilepsia partialis continua followed by status epilepticus with loss of consciousness." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK3795/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/sca-io/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK3795/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8AADB0DFC843010000000005F302C9.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK3795_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK3795_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/i-p/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/kms/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK3795_"><span class="title" itemprop="name">Infantile-Onset Spinocerebellar Ataxia</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonym: IOSCA, Mitochondrial DNA Depletion Syndrome 7</div><p class="contrib-group"><span itemprop="author">Tuula L&#x000f6;nnqvist</span>, MD, PhD.</p><a data-jig="ncbitoggler" href="#__NBK3795_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK3795_ai__"><div class="contrib half_rhythm"><span itemprop="author">Tuula L&#x000f6;nnqvist</span>, MD, PhD<div class="affiliation small">Assistant Professor, Department of Child Neurology<br />Children's Hospital<br />Helsinki University Hospital<br />Helsinki, Finland<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="if.suh@tsivqnnol.aluut" class="oemail">if.suh@tsivqnnol.aluut</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">January 27, 2009</span>; Last Update: <span itemprop="dateModified">April 19, 2018</span>.</p><p><em>Estimated reading time: 19 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="sca-io.Summary" itemprop="description"><h2 id="_sca-io_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Infantile-onset spinocerebellar ataxia (IOSCA) is a severe, progressive neurodegenerative disorder characterized by normal development until age one year, followed by onset of ataxia, muscle hypotonia, loss of deep-tendon reflexes, and athetosis. Ophthalmoplegia and sensorineural deafness develop by age seven years. By adolescence, <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals are profoundly deaf and no longer ambulatory; sensory axonal neuropathy, optic atrophy, autonomic nervous system dysfunction, and hypergonadotropic hypogonadism in females become evident. Epilepsy can develop into a serious and often fatal encephalopathy: myoclonic jerks or focal clonic seizures that progress to epilepsia partialis continua followed by status epilepticus with loss of consciousness.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of IOSCA is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with typical clinical findings and identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>TWNK</i> by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Hearing loss, sensory axonal neuropathy, ataxia, psychotic behavior, and severe depression are treated in the usual manner. Conventional antiepileptic drugs (phenytoin and phenobarbital) are ineffective in most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p><p><i>Surveillance:</i> Small children: neurologic, audiologic, and ophthalmologic evaluations every six to 12 months; neurophysiologic studies when indicated; brain MRI every three to five years. Adolescents and adults: neurologic examination yearly; audiologic and ophthalmologic examinations every one to two years; EEG and brain MRI at least during status epilepticus.</p><p><i>Agents/circumstances to avoid:</i> Valproate, which can cause significant elevation of serum concentration of bilirubin and liver enzymes.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>IOSCA is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk relatives and <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> for pregnancies at increased risk are possible if the pathogenic variants in the family are known.</p></div></div><div id="sca-io.Diagnosis"><h2 id="_sca-io_Diagnosis_">Diagnosis</h2><p>Infantile-onset spinocerebellar ataxia (IOSCA) is a clinical spectrum that was originally described in individuals of Finnish descent; however, the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> has been expanded by the identification of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals of non-Finnish descent whose features may deviate from the originally described "classic" phenotype</p><p>Clinical diagnostic criteria for IOSCA were published by <a class="bk_pop" href="#sca-io.REF.koskinen.1994a.509">Koskinen et al [1994a]</a> and <a class="bk_pop" href="#sca-io.REF.koskinen.1994b.50">Koskinen et al [1994b]</a>.</p><div id="sca-io.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Infantile-onset spinocerebellar ataxia (IOSCA) <b>should be suspected</b> in individuals with the following clinical features and supportive laboratory findings.</p><p><b>Clinical features.</b> After normal early development, children with IOSCA typically display the following clinical features, often in successive order (although the time and order of presentation of clinical symptoms can vary in those who are not of Finnish ancestry) starting in the second year of life:</p><ul><li class="half_rhythm"><div>Spinocerebellar ataxia</div></li><li class="half_rhythm"><div>Muscle hypotonia</div></li><li class="half_rhythm"><div>Athetoid movements</div></li><li class="half_rhythm"><div>Loss of deep-tendon reflexes</div></li><li class="half_rhythm"><div>Hearing deficit</div></li><li class="half_rhythm"><div>Ophthalmoplegia</div></li><li class="half_rhythm"><div>Optic atrophy</div></li><li class="half_rhythm"><div>Primary hypergonadotropic hypogonadism in females</div></li><li class="half_rhythm"><div>Epileptic encephalopathy</div></li></ul><p><b>Supportive laboratory findings</b></p><ul><li class="half_rhythm"><div>Normal routine laboratory and metabolic screening tests</div></li><li class="half_rhythm"><div>Normal muscle morphology and respiratory chain enzyme analyses</div></li><li class="half_rhythm"><div>Absence of mitochondrial DNA (mtDNA) <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> and/or depletion in muscle; however:</div><ul><li class="half_rhythm"><div>A few <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals had mtDNA depletion in the liver [<a class="bk_pop" href="#sca-io.REF.hakonen.2007.3032">Hakonen et al 2007</a>, <a class="bk_pop" href="#sca-io.REF.sarzi.2007.579">Sarzi et al 2007</a>].</div></li><li class="half_rhythm"><div>Postmortem material has revealed complex I deficiency and mtDNA depletion in the brain [<a class="bk_pop" href="#sca-io.REF.hakonen.2008.3822">Hakonen et al 2008</a>].</div></li></ul></li></ul><p>Note: Muscle biopsy with histology and respiratory chain enzyme analysis are not required for the diagnosis of IOSCA.</p></div><div id="sca-io.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of IOSCA <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with typical clinical findings and the identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>TWNK</i> by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK3795/table/sca-io.T.molecular_genetic_testing_used/?report=objectonly" target="object" rid-figpopup="figscaioTmoleculargenetictestingused" rid-ob="figobscaioTmoleculargenetictestingused">Table 1</a>).</p><p>Molecular genetic testing approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b>, use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>, and <b>more comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b>.</p><p><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b></p><ul><li class="half_rhythm"><div class="half_rhythm">Targeted analysis for the founder pathogenic <a class="figpopup" href="/books/NBK3795/table/sca-io.T.twnk_pathogenic_variants_discus/?report=objectonly" target="object" rid-figpopup="figscaioTtwnkpathogenicvariantsdiscus" rid-ob="figobscaioTtwnkpathogenicvariantsdiscus">c.1523A&#x0003e;G</a> variant in <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 3 can be performed first in individuals of Finnish ancestry [<a class="bk_pop" href="#sca-io.REF.nikali.2005.2981">Nikali et al 2005</a>].</div><div class="half_rhythm">Note: All individuals with the IOSCA <a class="def" href="/books/n/gene/glossary/def-item/founder-variant/">founder variant</a> in <i>TWNK</i> have been identified in the genetically isolated population of Finland only, where IOSCA is the second-most common inherited ataxia [<a class="bk_pop" href="#sca-io.REF.nikali.2005.2981">Nikali et al 2005</a>]. Other <i>TWNK</i> variants have been described in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals of English [<a class="bk_pop" href="#sca-io.REF.hartley.2012">Hartley et al 2012</a>], Pakistani [<a class="bk_pop" href="#sca-io.REF.prasad.2013.190">Prasad et al 2013</a>], Indian [<a class="bk_pop" href="#sca-io.REF.faruq.2014">Faruq et al 2014</a>], and northern European descent [<a class="bk_pop" href="#sca-io.REF.pierce.2016.a001107">Pierce et al 2016</a>].</div></li><li class="half_rhythm"><div class="half_rhythm">In those who are not of known Finnish ancestry or in whom targeted testing for the Finnish <a class="def" href="/books/n/gene/glossary/def-item/founder-variant/">founder variant</a> identifies one or no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of <i>TWNK</i> may be performed.</div></li></ul><p><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>TWNK</i> and other genes of interest (see <a href="#sca-io.Differential_Diagnosis">Differential Diagnosis</a>) may be considered. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</p><p>For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</p><p><b>More comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (when available) including <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a>, mitochondrial sequencing, and <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a> may be considered. Such testing may provide or suggest a diagnosis not previously considered (e.g., mutation of a different <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> or genes that results in a similar clinical presentation).</p><p>For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</p><div id="sca-io.T.molecular_genetic_testing_used" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Infantile-Onset Spinocerebellar Ataxia</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK3795/table/sca-io.T.molecular_genetic_testing_used/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__sca-io.T.molecular_genetic_testing_used_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_sca-io.T.molecular_genetic_testing_used_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_sca-io.T.molecular_genetic_testing_used_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Test Method</th><th id="hd_h_sca-io.T.molecular_genetic_testing_used_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by This Method</th></tr></thead><tbody><tr><td headers="hd_h_sca-io.T.molecular_genetic_testing_used_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>TWNK</i></td><td headers="hd_h_sca-io.T.molecular_genetic_testing_used_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_sca-io.T.molecular_genetic_testing_used_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100%&#x000a0;<sup>4,&#x000a0;5</sup></td></tr><tr><td headers="hd_h_sca-io.T.molecular_genetic_testing_used_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>6</sup></td><td headers="hd_h_sca-io.T.molecular_genetic_testing_used_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None reported&#x000a0;<sup>7</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="sca-io.TF.1.1"><p class="no_margin">See <a href="/books/NBK3795/#sca-io.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="sca-io.TF.1.2"><p class="no_margin">See <a href="#sca-io.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="sca-io.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="sca-io.TF.1.4"><p class="no_margin">In the <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> / flanking <a class="def" href="/books/n/gene/glossary/def-item/intron/">intron</a> regions sequenced; pathogenic variants in non-sequenced intron and regulatory regions are not detected.</p></div></dd><dt>5. </dt><dd><div id="sca-io.TF.1.5"><p class="no_margin">Sequence analysis detects the Finnish <a class="def" href="/books/n/gene/glossary/def-item/founder-variant/">founder variant</a> and others, including <a class="figpopup" href="/books/NBK3795/table/sca-io.T.twnk_pathogenic_variants_discus/?report=objectonly" target="object" rid-figpopup="figscaioTtwnkpathogenicvariantsdiscus" rid-ob="figobscaioTtwnkpathogenicvariantsdiscus">c.1287C&#x0003e;T</a> and <a class="figpopup" href="/books/NBK3795/table/sca-io.T.twnk_pathogenic_variants_discus/?report=objectonly" target="object" rid-figpopup="figscaioTtwnkpathogenicvariantsdiscus" rid-ob="figobscaioTtwnkpathogenicvariantsdiscus">c.952G&#x0003e;A</a>, which have been detected in the <a class="def" href="/books/n/gene/glossary/def-item/compound-heterozygous/">compound heterozygous</a> state with <a class="figpopup" href="/books/NBK3795/table/sca-io.T.twnk_pathogenic_variants_discus/?report=objectonly" target="object" rid-figpopup="figscaioTtwnkpathogenicvariantsdiscus" rid-ob="figobscaioTtwnkpathogenicvariantsdiscus">c.1523A&#x0003e;G</a> (see <a href="#sca-io.Molecular_Genetics">Molecular Genetics</a>).</p></div></dd><dt>6. </dt><dd><div id="sca-io.TF.1.6"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>7. </dt><dd><div id="sca-io.TF.1.7"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> has not identified any deletions/duplications.</p></div></dd></dl></div></div></div></div></div><div id="sca-io.Clinical_Characteristics"><h2 id="_sca-io_Clinical_Characteristics_">Clinical Characteristics</h2><div id="sca-io.Clinical_Description"><h3>Clinical Description</h3><p>Infantile-onset spinocerebellar ataxia (IOSCA) was originally described in individuals of Finnish descent who had <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic founder variants in <i>TWINK</i>. Individuals with this <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a> were described as having the classic features on which clinical diagnostic criteria are based. However, <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals from multiple ethnicities who have pathogenic variants in <i>TWINK</i> that are different from the original <a class="def" href="/books/n/gene/glossary/def-item/founder-variant/">founder variant</a> have now been described. Clinical features in these individuals have expanded the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of IOSCA. These affected individuals are sometimes referred to as having "atypical IOSCA." However, IOSCA represents a continuum in which the clinical differences between affected individuals are due to the underlying pathogenic variants in <i>TWINK</i> (see <a href="#sca-io.GenotypePhenotype_Correlations">Genotype-Phenotype Correlations</a>).</p><p><b>Classic infantile-onset spinocerebellar ataxia (IOSCA)</b> is a severe, progressive neurodegenerative disorder [<a class="bk_pop" href="#sca-io.REF.koskinen.1994b.50">Koskinen et al 1994b</a>]. Affected children are born after an uneventful pregnancy and develop normally until age one year, when the first clinical symptoms of ataxia, muscle hypotonia, loss of deep-tendon reflexes, and athetosis appear. Ophthalmoplegia and sensorineural deafness develop by school age (age 7 years). By adolescence sensory axonal neuropathy, optic atrophy, and hypergonadotropic hypogonadism in females become evident. Migraine, psychiatric symptoms, and epilepsy are late manifestations.</p><p>By adolescence <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals are no longer ambulatory, being dependent on either a walker or wheelchair. The hearing deficit is severe (&#x0003e;100 dB) and communication relies on sign language. Progressive <i>pes cavus</i> foot deformity and neurogenic scoliosis are common, as well as autonomic nervous system dysfunction, which manifests as increased perspiration, difficulty with urination and/or urinary incontinence, and obstipation.</p><p>The supratentorial brain (i.e., cerebral cortex, cerebral white matter, basal ganglia, and other deep brain nuclei) is well preserved until the onset of epilepsy. In 15 children, epilepsy developed into a serious encephalopathy, beginning at ages two and four years in those who were compound heterozygotes for the Finnish <a class="def" href="/books/n/gene/glossary/def-item/founder-variant/">founder variant</a> and another <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, and between ages 15 and 34 years (mean age 24 years) in homozygotes for the Finnish founder variant. The seizures were myoclonic jerks or focal clonic seizures that progressed to epilepsia partialis continua and further to status epilepticus with loss of consciousness and tonic-clonic seizures. Death of nine of these 15 individuals was directly or indirectly related to epilepsy. The oldest individual (without epilepsy) who is <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> for the Finnish founder variant is alive at age 50 years.</p><p><b>Atypical IOSCA.</b> The clinical course is more rapid and severe in individuals with certain genotypes (see <a href="#sca-io.GenotypePhenotype_Correlations">Genotype-Phenotype Correlations</a>) and is characterized by severe early-onset encephalopathy and signs of liver involvement. The clinical manifestations include hypotonia, athetosis, sensory neuropathy, ataxia, hearing deficit, ophthalmoplegia, intractable epilepsy, and elevation of serum transaminases. The liver may show mtDNA depletion, whereas the muscle mtDNA is only slightly affected.</p><p><b>Neuroimaging.</b> The supratentorial findings of cortical edema and later cortical and central atrophy appear at the time of and after the onset of epilepsy. The cortical edema is of a nonvascular distribution. The area of swollen cortex varied from multiple small lesions to the involvement of the whole hemisphere, thalamus, and caudate nucleus. In diffusion-weighted imaging (DWI), the lesions showed restricted diffusion, thus behaving like early ischemic changes. Some of these lesions were reversible, but a T<sub>1</sub>-weighted hyperintense cortical signal compatible with cortical laminar necrosis developed in individuals with recurrent status epilepticus. Supratentorial cortical and central atrophy was seen in all individuals with intractable status epilepticus, but not in children or adults without refractory epilepsy. Epileptic encephalopathy in IOSCA is similar to that seen in other mitochondrial disorders, including <a href="/books/n/gene/melas/">MELAS</a>.</p><p>Spinocerebellar degeneration progresses gradually with increasing age. Serial brain MRI imaging reveals cerebellar, cortical, and brain stem atrophy with increased signal intensity in the cerebellar white matter on T<sub>2</sub>-weighted images [<a class="bk_pop" href="#sca-io.REF.koskinen.1995b.1427">Koskinen et al 1995b</a>].</p><p><b>Neuropathology.</b> Postmortem studies show moderate brain stem and cerebellar atrophy and severe atrophic changes in the dorsal roots, posterior columns, and posterior spinocerebellar tracts of the spinal cord [<a class="bk_pop" href="#sca-io.REF.koskinen.1994a.509">Koskinen et al 1994a</a>, <a class="bk_pop" href="#sca-io.REF.l_nnqvist.1998.57">L&#x000f6;nnqvist et al 1998</a>].</p></div><div id="sca-io.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p><b>Classic IOSCA.</b> Within and between families, individuals with IOSCA who are <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> for the <a class="figpopup" href="/books/NBK3795/table/sca-io.T.twnk_pathogenic_variants_discus/?report=objectonly" target="object" rid-figpopup="figscaioTtwnkpathogenicvariantsdiscus" rid-ob="figobscaioTtwnkpathogenicvariantsdiscus">c.1523A&#x0003e;G</a> <a class="def" href="/books/n/gene/glossary/def-item/founder-variant/">founder variant</a> show similar early-onset symptoms and clinical course, except for the onset of epilepsy [<a class="bk_pop" href="#sca-io.REF.koskinen.1994b.50">Koskinen et al 1994b</a>].</p><p><b>Atypical IOSCA.</b> Individuals who are not <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> for the pathogenic Finnish <a class="def" href="/books/n/gene/glossary/def-item/founder-variant/">founder variant</a> may have signs and symptoms that develop and progress differently from the "classic" clinical course described above. For example:</p><ul><li class="half_rhythm"><div>Individuals who are compound heterozygotes for <a class="figpopup" href="/books/NBK3795/table/sca-io.T.twnk_pathogenic_variants_discus/?report=objectonly" target="object" rid-figpopup="figscaioTtwnkpathogenicvariantsdiscus" rid-ob="figobscaioTtwnkpathogenicvariantsdiscus">c.[1523A&#x0003e;G];[952G&#x0003e;A]</a> or homozygotes for <a class="figpopup" href="/books/NBK3795/table/sca-io.T.twnk_pathogenic_variants_discus/?report=objectonly" target="object" rid-figpopup="figscaioTtwnkpathogenicvariantsdiscus" rid-ob="figobscaioTtwnkpathogenicvariantsdiscus">c.1370C&#x0003e;T</a> have very early onset of symptoms and a rapidly progressive disease course that may include hepatic involvement (see <a href="#sca-io.Clinical_Description">Clinical Description</a>, <b>Atypical IOSCA</b>).</div></li><li class="half_rhythm"><div><a class="bk_pop" href="#sca-io.REF.prasad.2013.190">Prasad et al [2013]</a> identified <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic <a class="figpopup" href="/books/NBK3795/table/sca-io.T.twnk_pathogenic_variants_discus/?report=objectonly" target="object" rid-figpopup="figscaioTtwnkpathogenicvariantsdiscus" rid-ob="figobscaioTtwnkpathogenicvariantsdiscus">c.1183T&#x0003e;C</a> variants in three deceased sibs of a <a class="def" href="/books/n/gene/glossary/def-item/consanguineous/">consanguineous</a> Pakistani family. The <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> sibs presented with cholestatic liver disease, hypotonia, severe failure to thrive, recurrent vomiting, renal tubulopathy, and a progressive neurodegenerative course. Unusual clinical features in these individuals included renal tubulopathy as well as the lack of epileptic encephalopathy.</div></li></ul></div><div id="sca-io.Nomenclature"><h3>Nomenclature</h3><p>IOSCA was originally known as OHAHA (<i>o</i>phthalmoplegia, <i>h</i>ypoacusis, <i>a</i>taxia, <i>h</i>ypotonia, <i>a</i>thetosis) syndrome [<a class="bk_pop" href="#sca-io.REF.kallio.1985.84">Kallio &#x00026; Jauhiainen 1985</a>].</p></div><div id="sca-io.Prevalence"><h3>Prevalence</h3><p>The <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> frequency of the <a class="figpopup" href="/books/NBK3795/table/sca-io.T.twnk_pathogenic_variants_discus/?report=objectonly" target="object" rid-figpopup="figscaioTtwnkpathogenicvariantsdiscus" rid-ob="figobscaioTtwnkpathogenicvariantsdiscus">c.1523A&#x0003e;G</a> <a class="def" href="/books/n/gene/glossary/def-item/founder-variant/">founder variant</a> varies between 0.44% (1:230) in all of Finland and 2.0%-2.4% (1:50-1:40) in selected sub-isolates in Ostrobothnia and Savo.</p></div></div><div id="sca-io.Genetically_Related_Allelic_Disor"><h2 id="_sca-io_Genetically_Related_Allelic_Disor_">Genetically Related (Allelic) Disorders</h2><div id="sca-io.T.other_phenotypes_caused_by_path" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Other Phenotypes Caused by Pathogenic Variants in <i>TWNK</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK3795/table/sca-io.T.other_phenotypes_caused_by_path/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__sca-io.T.other_phenotypes_caused_by_path_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_sca-io.T.other_phenotypes_caused_by_path_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Phenotype</th><th id="hd_h_sca-io.T.other_phenotypes_caused_by_path_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_sca-io.T.other_phenotypes_caused_by_path_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference</th></tr></thead><tbody><tr><td headers="hd_h_sca-io.T.other_phenotypes_caused_by_path_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Autosomal dominant progressive external ophthalmoplegia</td><td headers="hd_h_sca-io.T.other_phenotypes_caused_by_path_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_sca-io.T.other_phenotypes_caused_by_path_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See <a href="#sca-io.Autosomal_Dominant_Progressive_Ex">below</a></td></tr><tr><td headers="hd_h_sca-io.T.other_phenotypes_caused_by_path_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Novel <i>TWNK</i>-related ataxia condition</td><td headers="hd_h_sca-io.T.other_phenotypes_caused_by_path_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_sca-io.T.other_phenotypes_caused_by_path_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See <a href="#sca-io.Novel_TWNKRelated_Ataxia_Conditio">below</a></td></tr><tr><td headers="hd_h_sca-io.T.other_phenotypes_caused_by_path_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Perrault syndrome 5</td><td headers="hd_h_sca-io.T.other_phenotypes_caused_by_path_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_sca-io.T.other_phenotypes_caused_by_path_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">OMIM <a href="http://www.omim.org/entry/616138" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">616138</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a></p></div></dd><dt></dt><dd><div><p class="no_margin">AD = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a></p></div></dd><dt></dt><dd><div><p class="no_margin">AR = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a></p></div></dd></dl></div></div></div><div id="sca-io.Autosomal_Dominant_Progressive_Ex"><h3>Autosomal Dominant Progressive External Ophthalmoplegia</h3><p>Autosomal dominant progressive external ophthalmoplegia (adPEO) (OMIM <a href="https://www.omim.org/phenotypicSeries/PS157640" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PS157640</a>) is a heterogeneous late-onset neuromuscular disorder sharing a spectrum of findings with IOSCA but characterized by accumulation of multiple deletions of mtDNA in muscle, brain, and heart; adPEO-causing pathogenic variants in the linker region of twinkle invariably result in mtDNA deletions caused by impaired hexamerization of the multimer helicase activity, and thus a <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> different from IOSCA. Typical clinical findings include exercise intolerance, muscle weakness, peripheral neuropathy, deafness, ataxia, and cataracts. Psychiatric problems can also occur [<a class="bk_pop" href="#sca-io.REF.zeviani.1989.309">Zeviani et al 1989</a>, <a class="bk_pop" href="#sca-io.REF.suomalainen.1992.61">Suomalainen et al 1992</a>].</p></div><div id="sca-io.Novel_TWNKRelated_Ataxia_Conditio"><h3>Novel <i>TWNK</i>-Related Ataxia Condition</h3><p><a class="bk_pop" href="#sca-io.REF.park.2014.171">Park et al [2014]</a> reported a Korean family with two <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals who were found through <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> to have <a class="def" href="/books/n/gene/glossary/def-item/compound-heterozygous/">compound heterozygous</a> pathogenic variants in <i>TWNK</i> (c.[1460C&#x0003e;T];[1485-1G&#x0003e;A]). The IOSCA-causing Finnish <a class="def" href="/books/n/gene/glossary/def-item/founder-variant/">founder variant</a> (OMIM <a href="http://omim.org/entry/606075" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">606075</a>; see .0012) was not detected. The Korean disease <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> shares many clinical features with IOSCA, but also includes myopathy and mtDNA deletions in skeletal muscle, neither of which is typical in IOSCA. Neither of the affected individuals from this Korean family has developed epileptic encephalopathy, a typical feature in IOSCA [<a class="bk_pop" href="#sca-io.REF.park.2014.171">Park et al 2014</a>]. Therefore, this may represent a newly recognized <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> condition.</p></div></div><div id="sca-io.Differential_Diagnosis"><h2 id="_sca-io_Differential_Diagnosis_">Differential Diagnosis</h2><p>Differential diagnosis for infantile-onset spinocerebellar ataxia (IOSCA) should include all early-onset cerebellar ataxias with sensory axonal neuropathy and epileptic encephalopathy.</p><p>The spinocerebellar degeneration in IOSCA is similar to that in <a href="/books/n/gene/friedreich/">Friedreich ataxia</a> and other mitochondrial disorders with axonal neuropathy.</p><p><a href="/books/n/gene/alpers/"><b><i>POLG-</i>related disorders</b></a><b>.</b>
<i>POLG</i>, a nuclear <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> that encodes mitochondrial DNA polymerase subunit gamma-1, is a functional partner of twinkle in the mtDNA replication fork [<a class="bk_pop" href="#sca-io.REF.hakonen.2007.3032">Hakonen et al 2007</a>]. This close biologic relationship explains the phenotypic overlap of the disorders caused by <i>TWNK</i> pathogenic variants and those caused by <i>POLG</i> pathogenic variants. Of note, disorders caused by <i>POLG</i> pathogenic variants are more common than disorders caused by <i>TWNK</i> pathogenic variants.</p><p>The syndromes associated with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>POLG</i> pathogenic variants range from an infantile hepatoencephalopathy (Alpers-Huttenlocher syndrome) to ataxia neuropathy spectrum (ANS) disorders.</p><ul><li class="half_rhythm"><div>Early encephalopathy, sensory axonal neuropathy, epilepsy, and signs of hepatopathy with mtDNA depletion in the liver are seen in individuals with <i>POLG</i>-associated Alpers-Huttenlocher syndrome [<a class="bk_pop" href="#sca-io.REF.hakonen.2007.3032">Hakonen et al 2007</a>, <a class="bk_pop" href="#sca-io.REF.sarzi.2007.579">Sarzi et al 2007</a>].</div></li><li class="half_rhythm"><div>While IOSCA and ANS share clinical features, spinocerebellar degeneration starts earlier and progresses faster in IOSCA than in ANS [<a class="bk_pop" href="#sca-io.REF.koskinen.1994a.509">Koskinen et al 1994a</a>, <a class="bk_pop" href="#sca-io.REF.l_nnqvist.1998.57">L&#x000f6;nnqvist et al 1998</a>, <a class="bk_pop" href="#sca-io.REF.hakonen.2007.3032">Hakonen et al 2007</a>, <a class="bk_pop" href="#sca-io.REF.hakonen.2008.3822">Hakonen et al 2008</a>].</div></li></ul><p><a href="/books/n/gene/ataxia-telangiectas/"><b>Ataxia-telangiectasia</b></a>
<b>(A-T)</b> is characterized by progressive cerebellar ataxia beginning between ages one and four years, oculomotor apraxia, frequent infections, choreoathetosis, telangiectasias of the conjunctivae, immunodeficiency, and an increased risk for malignancy, particularly leukemia and lymphoma. Individuals with A-T are unusually sensitive to ionizing radiation.</p><p>Diagnosis of A-T relies on clinical findings including slurred speech, truncal ataxia, and oculomotor apraxia; family history; and neuroimaging. Testing that supports the diagnosis includes serum alphafetoprotein concentration (elevated in &#x0003e;95% of individuals with A-T), identification of a 7;14 <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/translocation/">translocation</a> on routine <a class="def" href="/books/n/gene/glossary/def-item/karyotype/">karyotype</a> of peripheral blood, the presence of immunodeficiency, and in vitro radiosensitivity assay. A-T is caused by <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>ATM</i>.</p><p>IOSCA is distinguished from A-T by: normal <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> studies, normal immune function, loss of deep-tendon reflexes, early ophthalmoplegia, deafness, and absence of telangiectasias.</p></div><div id="sca-io.Management"><h2 id="_sca-io_Management_">Management</h2><div id="sca-io.Evaluations_Following_Initial_Dia"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with infantile-onset spinocerebellar ataxia (IOSCA), the following are recommended (if not already been completed as part of the evaluation that led to the diagnosis):</p><ul><li class="half_rhythm"><div>Neurologic examination to evaluate the grade of ataxia and neuropathy</div></li><li class="half_rhythm"><div>Audiologic examination to evaluate the degree of hearing loss and need for hearing aids</div></li><li class="half_rhythm"><div>Ophthalmologic examination to evaluate the grade of ophthalmoparesis and optic atrophy</div></li><li class="half_rhythm"><div>Neurophysiologic examinations</div><ul><li class="half_rhythm"><div>ENMG (electroneuromyography)</div></li><li class="half_rhythm"><div>SEP (somatosensory evoked potentials). Note: Changes in SEP occur early in the disease course and correlate with sensory system involvement.</div></li><li class="half_rhythm"><div>VEP (visual evoked potentials)</div></li></ul></li><li class="half_rhythm"><div>Brain MRI</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="sca-io.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>Treatment is symptomatic:</p><ul><li class="half_rhythm"><div><b>Deafness.</b> Hearing aids, speech therapy, and sign language to support social adaptation and prevent educational problems in children with IOSCA. Computers may be a valuable aid in support of communication and learning (see <a href="/books/n/gene/deafness-overview/">Hereditary Hearing Loss and Deafness Overview</a>).</div></li><li class="half_rhythm"><div><b>Sensory axonal neuropathy.</b> Physiotherapy and orthoses to prevent foot and spine deformity; supportive shoes, splints, and braces; orthopedic surgery for foot deformities (<i>pes cavus</i>) and spine deformities (scoliosis); foot care to treat calluses and ulcerations</div></li><li class="half_rhythm"><div><b>Ataxia.</b> A walker, wheelchair, physiotherapy, occupational therapy</div></li><li class="half_rhythm"><div><b>Epilepsy.</b> Conventional antiepileptic drugs (phenytoin and phenobarbital) are ineffective in most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals [<a class="bk_pop" href="#sca-io.REF.l_nnqvist.2009.1553">L&#x000f6;nnqvist et al 2009</a>].</div><ul><li class="half_rhythm"><div>Some <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have benefited from lamotrigine, levetiracetam, topiramate, or lacosamide.</div></li><li class="half_rhythm"><div>Benzodiazepines, especially midazolam infusion, when started early in status epilepticus, were occasionally effective.</div></li><li class="half_rhythm"><div>Oxcarbazepine has some effect, but hyponatremia is a troublesome side effect.</div></li></ul></li><li class="half_rhythm"><div><b>Psychiatric symptoms.</b> Antipsychotics (neurolepts, risperidone, olanzpine) to prevent psychotic behavior and antidepressants (SSRIs) for severe depression</div></li></ul></div><div id="sca-io.Surveillance"><h3>Surveillance</h3><p><b>Small children</b></p><ul><li class="half_rhythm"><div>Neurologic, audiologic, and ophthalmologic evaluation every six to 12 months</div></li><li class="half_rhythm"><div>Neurophysiologic studies when clinically indicated</div></li><li class="half_rhythm"><div>Brain MRI every three to five years</div></li></ul><p><b>Adolescents and adults</b></p><ul><li class="half_rhythm"><div>Neurologic examination annually</div></li><li class="half_rhythm"><div>Audiologic and ophthalmologic examinations every one to two years</div></li><li class="half_rhythm"><div>EEG and brain MRI at least during status epilepticus</div></li></ul></div><div id="sca-io.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Valproate is contraindicated in those with IOSCA, as it is in other disorders that potentially affect mitochondrial function in liver. Valproate caused significant elevation of liver enzymes (alanine aminotransferase: 232 units/L [normal: 10-35 U/L]; gamma-GT: 160 U/L [normal: 5-50 U/L]) and icterus with elevated bilirubin levels (total: 224 &#x003bc;mol/L [normal: 5-25 &#x003bc;mol/L]; conjugated: 160 &#x003bc;mol/L [normal:1-8 &#x003bc;mol/L]) in one <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual, and similar elevation of liver transaminases in another. When valproate was discontinued, icterus resolved and liver enzymes normalized.</p></div><div id="sca-io.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#sca-io.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="sca-io.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="sca-io.Genetic_Counseling"><h2 id="_sca-io_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="sca-io.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Infantile-onset spinocerebellar ataxia (IOSCA) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p></div><div id="sca-io.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual are obligate heterozygotes (i.e., carriers of one <i>TWNK</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Individuals with IOSCA do not reproduce.</p><ul><li class="half_rhythm"><div>Females with IOSCA have hypergonadotropic hypogonadism, indicative of ovarian failure.</div></li><li class="half_rhythm"><div>Males with IOSCA are too severely disabled to reproduce [<a class="bk_pop" href="#sca-io.REF.koskinen.1995a.263">Koskinen et al 1995a</a>].</div></li></ul><p><b>Other family members.</b> Each sib of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents is at 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of a <i>TWNK</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div><div id="sca-io.Carrier_Heterozygote_Detection"><h3>Carrier (Heterozygote) Detection</h3><p>Carrier testing for at-risk relatives requires prior identification of the <i>TWNK</i> pathogenic variants in the family.</p></div><div id="sca-io.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are carriers or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="sca-io.Prenatal_Testing_and_Preimplantat"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>TWNK</i> pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p></div></div><div id="sca-io.Resources"><h2 id="_sca-io_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Alexander Graham Bell Association for the Deaf and Hard of Hearing</b></div><div>3417 Volta Place Northwest</div><div>Washington DC 20007</div><div><b>Phone:</b> 866-337-5220 (toll-free); 202-337-5220; 202-337-5221 (TTY)</div><div><b>Fax:</b> 202-337-8314</div><div><b>Email:</b> info@agbell.org</div><div><a href="http://www.agbell.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Listening and Spoken Language Knowledge Center</a></div></li><li class="half_rhythm"><div><b>American Society for Deaf Children (ASDC)</b></div><div>800 Florida Avenue Northeast</div><div>Suite 2047</div><div>Washington DC 20002-3695</div><div><b>Phone:</b> 800-942-2732 (Toll-free Parent Hotline); 866-895-4206 (toll free voice/TTY)</div><div><b>Fax:</b> 410-795-0965</div><div><b>Email:</b> info@deafchildren.org; asdc@deafchildren.org</div><div><a href="http://www.deafchildren.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.deafchildren.org</a></div></li><li class="half_rhythm"><div><b>euro-ATAXIA (European Federation of Hereditary Ataxias)</b></div><div>Ataxia UK</div><div>Lincoln House, Kennington Park, 1-3 Brixton Road</div><div>London SW9 6DE</div><div>United Kingdom</div><div><b>Phone:</b> +44 (0) 207 582 1444</div><div><b>Email:</b> smillman@ataxia.org.uk</div><div><a href="https://www.euroataxia.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.euroataxia.org</a></div></li><li class="half_rhythm"><div><b>Finnish Federation of the Hard of Hearing (FFHOH)</b></div><div>Ilkantie 4</div><div>PL 51</div><div>Helsinki 00400</div><div>Finland</div><div><b>Phone:</b> +358 (0)9 5803 830</div><div><b>Fax:</b> +358 (0)9 5803 331 </div><div><b>Email:</b> etunimi.sukunimi@kuuloliitto.fi</div><div><a href="https://www.kuuloliitto.fi/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.kuuloliitto.fi</a></div></li><li class="half_rhythm"><div><b>Finnish Network for Rare Diseases</b></div><div>Finland</div><div><a href="https://www.harvinaiset.fi/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.harvinaiset.fi</a></div></li><li class="half_rhythm"><div><b>National Ataxia Foundation</b></div><div>2600 Fernbrook Lane</div><div>Suite 119</div><div>Minneapolis MN 55447</div><div><b>Phone:</b> 763-553-0020</div><div><b>Email:</b> naf@ataxia.org</div><div><a href="http://www.ataxia.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ataxia.org</a></div></li><li class="half_rhythm"><div><b>CoRDS Registry</b></div><div>Sanford Research</div><div>2301 East 60th Street North</div><div>Sioux Falls SD 57104</div><div><b>Phone:</b> 605-312-6423</div><div><b>Email:</b> sanfordresearch@sanfordhealth.org</div><div><a href="http://www.sanfordresearch.org/SpecialPrograms/cords/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CoRDS Registry</a></div></li></ul></div><div id="sca-io.Molecular_Genetics"><h2 id="_sca-io_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="sca-io.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Infantile-Onset Spinocerebellar Ataxia: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK3795/table/sca-io.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__sca-io.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_sca-io.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_sca-io.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_sca-io.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_sca-io.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_sca-io.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_sca-io.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/56652" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>TWNK</i></a></td><td headers="hd_b_sca-io.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=56652" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">10q24<wbr style="display:inline-block"></wbr>​.31</a></td><td headers="hd_b_sca-io.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q96RR1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Twinkle protein, mitochondrial</a></td><td headers="hd_b_sca-io.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=TWNK" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">TWNK</a></td><td headers="hd_b_sca-io.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=TWNK[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">TWNK</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="sca-io.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="sca-io.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Infantile-Onset Spinocerebellar Ataxia (<a href="/omim/271245,606075" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK3795/table/sca-io.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__sca-io.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/271245" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">271245</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE); MTDPS7</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/606075" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">606075</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">TWINKLE mtDNA HELICASE; TWNK</td></tr></tbody></table></div></div><div id="sca-io.Molecular_Genetic_Pathogenesis"><h3>Molecular Genetic Pathogenesis</h3><p>Infantile-onset spinocerebellar ataxia (IOSCA) is caused by pathogenic variants in <i>TWNK</i> (previously known as <i>C10orf2</i>), a ubiquitously expressed nuclear <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> encoding mitochondrial protein <a class="def" href="/books/n/gene/glossary/def-item/isoforms/">isoforms</a> twinkle and twinky [<a class="bk_pop" href="#sca-io.REF.nikali.2005.2981">Nikali et al 2005</a>].</p><p><b>Gene structure.</b> The longest <i>TWNK</i> transcript and major splice variant (<a href="/nuccore/NM_021830.4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_021830.4</a>) comprises five exons and encodes the protein isoform twinkle (also known as isoform A).</p><p>Transcript variant <a href="/nuccore/NM_001163812.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001163812.1</a> is a minor splice variant that encodes the distinct protein isoform known as twinky (also known as isoform B). This <a class="def" href="/books/n/gene/glossary/def-item/cdna/">cDNA</a> results from the use of a downstream <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 4 splice-donor site and leads to a 43-base-pair (bp) <a class="def" href="/books/n/gene/glossary/def-item/insertion/">insertion</a> between the regular exon 4 - exon 5 sequence, which causes a premature stop codon [<a class="bk_pop" href="#sca-io.REF.spelbrink.2001.223">Spelbrink et al 2001</a>].</p><p>For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>, transcript, and protein <a class="def" href="/books/n/gene/glossary/def-item/isoforms/">isoforms</a>, see <a href="/books/NBK3795/#sca-io.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants</b>. All pathogenic variants underlying IOSCA have been observed only in the genetically isolated Finnish population. See <a class="figpopup" href="/books/NBK3795/table/sca-io.T.twnk_pathogenic_variants_discus/?report=objectonly" target="object" rid-figpopup="figscaioTtwnkpathogenicvariantsdiscus" rid-ob="figobscaioTtwnkpathogenicvariantsdiscus">Table 3</a>.</p><p>To date, 24 individuals with IOSCA have been identified [<a class="bk_pop" href="#sca-io.REF.nikali.2005.2981">Nikali et al 2005</a>, <a class="bk_pop" href="#sca-io.REF.hakonen.2007.3032">Hakonen et al 2007</a>]:</p><ul><li class="half_rhythm"><div>21 homozygotes: c.[1523A&#x0003e;G];[1523A&#x0003e;G]</div></li><li class="half_rhythm"><div>Two compound heterozygotes: c.[1523A&#x0003e;G];[952G&#x0003e;A] [<a class="bk_pop" href="#sca-io.REF.hakonen.2007.3032">Hakonen et al 2007</a>]</div></li><li class="half_rhythm"><div>One compound <a class="def" href="/books/n/gene/glossary/def-item/heterozygote/">heterozygote</a>: c.[1523A&#x0003e;G];[1287C&#x0003e;T] [<a class="bk_pop" href="#sca-io.REF.nikali.2005.2981">Nikali et al 2005</a>]</div></li></ul><div id="sca-io.T.twnk_pathogenic_variants_discus" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p><i>TWNK</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK3795/table/sca-io.T.twnk_pathogenic_variants_discus/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__sca-io.T.twnk_pathogenic_variants_discus_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_sca-io.T.twnk_pathogenic_variants_discus_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_sca-io.T.twnk_pathogenic_variants_discus_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_sca-io.T.twnk_pathogenic_variants_discus_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_sca-io.T.twnk_pathogenic_variants_discus_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1287C&#x0003e;T</td><td headers="hd_h_sca-io.T.twnk_pathogenic_variants_discus_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ala429=&#x000a0;<sup>1</sup></td><td headers="hd_h_sca-io.T.twnk_pathogenic_variants_discus_1_1_1_3" rowspan="4" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/entrez/viewer.fcgi?db=nuccore&#x00026;id=39725941" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_021830<wbr style="display:inline-block"></wbr>​.4</a><br /><a href="/entrez/viewer.fcgi?db=protein&#x00026;id=39725942" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_068602<wbr style="display:inline-block"></wbr>​.2</a></td></tr><tr><td headers="hd_h_sca-io.T.twnk_pathogenic_variants_discus_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.952G&#x0003e;A</td><td headers="hd_h_sca-io.T.twnk_pathogenic_variants_discus_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ala318Thr</td></tr><tr><td headers="hd_h_sca-io.T.twnk_pathogenic_variants_discus_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1370C&#x0003e;T</td><td headers="hd_h_sca-io.T.twnk_pathogenic_variants_discus_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Thr457Ile</td></tr><tr><td headers="hd_h_sca-io.T.twnk_pathogenic_variants_discus_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1523A&#x0003e;G</td><td headers="hd_h_sca-io.T.twnk_pathogenic_variants_discus_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Tyr508Cys</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the author. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="sca-io.TF.3.1"><p class="no_margin">Designates that no variant was found that changes (or is predicted to change) the protein sequence, see <b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a></b>.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>TWNK</i> was originally cloned and the proteins resulting from the variant <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> of the gene, twinkle and twinky, were characterized by <a class="bk_pop" href="#sca-io.REF.spelbrink.2001.223">Spelbrink et al [2001]</a>. Twinkle and twinky are nuclear-encoded evolutionarily conserved mitochondrial proteins, twinkle being essentially involved in the maintenance of mtDNA.</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Twinkle</b> consists of 684 amino acids with a molecular mass of 77 kd. It forms stable hexamers that localize to mitochondrial nucleoids, mtDNA protein complexes within which the coupled replication and transcription of mtDNA takes place. Twinkle contains a 42-bp N-terminal mitochondrial localization signal, followed by a primase-related <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>, primase-helicase linker region, and a C-terminal helicase domain. Twinkle is structurally related to the bacteriophage T7 <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> 4 protein (primase/helicase) and is known to perform as an essential mtDNA-specific replicative helicase. Twinkle homologs have been detected in multiple model organisms [<a class="bk_pop" href="#sca-io.REF.spelbrink.2001.223">Spelbrink et al 2001</a>].</div><div class="half_rhythm">As a mtDNA-specific helicase, twinkle catalyzes ATP-dependent unwinding of duplex DNA with 5'&#x02192;3' polarity [<a class="bk_pop" href="#sca-io.REF.korhonen.2003.48627">Korhonen et al 2003</a>]. Its functional partner is mtDNA-polymerase gamma (POLG), with which it creates a processive replication machinery to use double-stranded DNA (dsDNA) as a template for single-stranded DNA (ssDNA) synthesis [<a class="bk_pop" href="#sca-io.REF.korhonen.2004.2423">Korhonen et al 2004</a>]. In the carboxyl terminus, critical residues between amino acids 572 and 596 of the 613-amino-acid polypeptide are essential for mtDNA helicase function in vivo, as shown in <i>Drosophila</i> cell cultures [<a class="bk_pop" href="#sca-io.REF.matsushima.2008.23964">Matsushima et al 2008</a>]. The N-terminal part of twinkle is needed for efficient binding to ssDNA. Truncations in this region reduce both helicase activity and functional efficacy of the mtDNA replisome [<a class="bk_pop" href="#sca-io.REF.farge.2008.393">Farge et al 2008</a>].</div><div class="half_rhythm">In addition to being essential for mtDNA integrity, twinkle regulates mtDNA copy number, as shown by analyzing overexpression of wild type twinkle in mice and human osteosarcoma cell lines [<a class="bk_pop" href="#sca-io.REF.tyynismaa.2004.3219">Tyynismaa et al 2004</a>]. In mice, increased expression of twinkle in muscle and heart resulted in a threefold increase in mtDNA copy number. In the human cell line, reducing twinkle expression by RNA interference mediated a rapid drop in mtDNA copy number.</div><div class="half_rhythm">Phylogenetic analyses showed that twinkle is widespread in the eukaryotic radiation and suggested that it may also function as a primase [<a class="bk_pop" href="#sca-io.REF.shutt.2006.588">Shutt &#x00026; Gray 2006</a>]. Indeed, the minimal mtDNA replisome consisting of twinkle, POLG, and mitochondrial single-strand binding protein (mtSSB) can support leading-strand mtDNA synthesis on a dsDNA template in vitro [<a class="bk_pop" href="#sca-io.REF.korhonen.2004.2423">Korhonen et al 2004</a>], but human mitochondrial RNA polymerase primes lagging-strand synthesis in vitro [<a class="bk_pop" href="#sca-io.REF.wanrooij.2008.11122">Wanrooij et al 2008</a>].</div><div class="half_rhythm">The primase/helicase linker region of twinkle is essential for hexamer formation, which is required for the ATP-hydrolyzing activity and DNA unwinding. Supposedly, the linker region interacts with amino acids in the helicase <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> of the adjacent monomer to form functional multimers [<a class="bk_pop" href="#sca-io.REF.korhonen.2008.691">Korhonen et al 2008</a>].</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Twinky.</b> Approximately 20% of the <i>TWNK</i> transcripts in human lymphoblasts code for the minor splice variant twinky [<a class="bk_pop" href="#sca-io.REF.nikali.2005.2981">Nikali et al 2005</a>; Nikali, unpublished data]. Twinky presents as a 66-kd product of 582 amino acids, lacking residues 579-684, as compared to twinkle, and terminating with four unique amino acids. Twinky presents as a monomer, is located diffusely within mitochondria, and shows no helicase activity [<a class="bk_pop" href="#sca-io.REF.spelbrink.2001.223">Spelbrink et al 2001</a>]. The function of twinky remains unknown.</div></li></ul><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The cellular pathogenesis of IOSCA originally remained largely unresolved, and current research has focused mainly on the major splice variant twinkle and the <a class="def" href="/books/n/gene/glossary/def-item/founder-variant/">founder variant</a> p.Tyr508Cys, even though the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is also present in the twinky protein.</p><p>The following describes the behavior and function of the twinkle protein isoform with the p.Tyr508Cys <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p>Small amounts of normal <i>TWNK</i> transcripts are not sufficient to rescue the IOSCA <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> caused by the c.1523A&#x0003e;G <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, whereas a full amount of mRNAs expressed from at least one normal <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> is required to preserve the development of a healthy individual [<a class="bk_pop" href="#sca-io.REF.nikali.2005.2981">Nikali et al 2005</a>].</p><ul><li class="half_rhythm"><div><b>In general.</b> The IOSCA-causing <a class="def" href="/books/n/gene/glossary/def-item/founder-variant/">founder variant</a> c.1523A&#x0003e;G (p.Tyr508Cys) is located in the helicase <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> of twinkle, just upstream of a conserved Walker B motif involved in dNTP binding [<a class="bk_pop" href="#sca-io.REF.nikali.2005.2981">Nikali et al 2005</a>]. It creates a conserved CXXCH-heme binding motif, observed in b-type cytochromes, but twinkle-p.Tyr508Cys does not bind heme covalently [<a class="bk_pop" href="#sca-io.REF.hakonen.2008.3822">Hakonen et al 2008</a>].</div></li><li class="half_rhythm"><div><b>Integrity of mtDNA.</b> In IOSCA, mtDNA stays intact, with no deletions or increased number of single-nucleotide variants (SNVs) observed in all tissues analyzed, including the brain [<a class="bk_pop" href="#sca-io.REF.nikali.2005.2981">Nikali et al 2005</a>, <a class="bk_pop" href="#sca-io.REF.hakonen.2008.3822">Hakonen et al 2008</a>].</div></li><li class="half_rhythm"><div><b>In vitro.</b> The <a class="def" href="/books/n/gene/glossary/def-item/founder-variant/">founder variant</a> c.1523A&#x0003e;G (p.Tyr508Cys) does not alter the subcellular localization or half-life of either twinkle or twinky [<a class="bk_pop" href="#sca-io.REF.nikali.2005.2981">Nikali et al 2005</a>]. Also helicase activity, hexamerization, and nucleoid structure remain normal [<a class="bk_pop" href="#sca-io.REF.hakonen.2008.3822">Hakonen et al 2008</a>].</div></li><li class="half_rhythm"><div><b>In the brain of an individual <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> with IOSCA.</b> In postmortem examination of an individual with IOSCA, the cerebellum and cerebrum showed mtDNA depletion (residual amounts 5%-20%), but did not harbor mtDNA deletions or a greater number of mtDNA SNVs. The cerebellar Purkinje and pyramidal cells showed reduced levels of respiratory chain complex I, and the large neurons of frontal cortex showed reduced levels of both complexes I and IV. IOSCA is associated with brain-specific depletion of mtDNA and reduced respiratory chain enzyme activities and should be considered a novel mtDNA depletion syndrome [<a class="bk_pop" href="#sca-io.REF.hakonen.2008.3822">Hakonen et al 2008</a>]. However, the mechanism by which the p.Tyr508Cys <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in twinkle causes mtDNA depletion remains to be investigated.</div></li></ul></div></div><div id="sca-io.References"><h2 id="_sca-io_References_">References</h2><div id="sca-io.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="sca-io.REF.farge.2008.393">Farge G, Holmlund T, Khvorostova J, Rofougaran R, Hofer A, Falkenberg M. The N-terminal domain of TWINKLE contributes to single-stranded DNA binding and DNA helicase activities. <span><span class="ref-journal">Nucleic Acids Res. </span>2008;<span class="ref-vol">36</span>:393–403.</span> [<a href="/pmc/articles/PMC2241861/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2241861</span></a>] [<a href="/pubmed/18039713" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18039713</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca-io.REF.faruq.2014">Faruq M, Narang A, Kumari R, Pandey R, Garg A, Behari M, Dash D, Srivastava AK, Mukerji M (2014) Novel mutations in typical and atypical genetic loci through exome sequencing in autosomal recessive cerebellar ataxia families. Clin Genet Oct;86:335-41. [<a href="/pubmed/24102492" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24102492</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca-io.REF.hakonen.2008.3822">Hakonen AH, Goffart S, Marjavaara S, Paetau A, Cooper H, Mattila K, Lampinen M, Sajantila A, L&#x000f6;nnqvist T, Spelbrink JN, Suomalainen A. Infantile-onset spinocerebellar ataxia and mitochondrial recessive ataxia syndrome are associated with neuronal complex I defect and mtDNA depletion. <span><span class="ref-journal">Hum Mol Genet. </span>2008;<span class="ref-vol">17</span>:3822–35.</span> [<a href="/pubmed/18775955" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18775955</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca-io.REF.hakonen.2007.3032">Hakonen AH, Isohanni P, Paetau A, Herva R, Suomalainen A, L&#x000f6;nnqvist T. Recessive Twinkle mutations in early onset encephalopathy with mtDNA depletion. <span><span class="ref-journal">Brain. </span>2007;<span class="ref-vol">130</span>:3032–40.</span> [<a href="/pubmed/17921179" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17921179</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca-io.REF.hartley.2012">Hartley JN, Booth FA, Del Bigio MR, Mhanni AA (2012) Novel autosomal recessive c10orf2 mutations causing infantile-onset spinocerebellar ataxia. Case Rep Pediatr. 2012;2012:303096. [<a href="/pmc/articles/PMC3424653/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3424653</span></a>] [<a href="/pubmed/22928142" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22928142</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca-io.REF.kallio.1985.84">Kallio AK, Jauhiainen T. A new syndrome of ophthalmoplegia, hypoacusis, ataxia, hypotonia and athetosis (OHAHA). <span><span class="ref-journal">Adv Audiol. </span>1985;<span class="ref-vol">3</span>:84–90.</span></div></li><li class="half_rhythm"><div class="bk_ref" id="sca-io.REF.korhonen.2003.48627">Korhonen JA, Gaspari M, Falkenberg M. TWINKLE has 5' -&#x0003e; 3' DNA helicase activity and is specifically stimulated by mitochondrial single-stranded DNA-binding protein. <span><span class="ref-journal">J Biol Chem. </span>2003;<span class="ref-vol">278</span>:48627–32.</span> [<a href="/pubmed/12975372" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12975372</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca-io.REF.korhonen.2008.691">Korhonen JA, Pande V, Holmlund T, Farge G, Pham XH, Nilsson L, Falkenberg M. Structure-function defects of the TWINKLE linker region in progressive external ophthalmoplegia. <span><span class="ref-journal">J Mol Biol. </span>2008;<span class="ref-vol">377</span>:691–705.</span> [<a href="/pubmed/18279890" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18279890</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca-io.REF.korhonen.2004.2423">Korhonen JA, Pham XH, Pellegrini M, Falkenberg M. Reconstitution of a minimal mtDNA replisome in vitro. <span><span class="ref-journal">EMBO J. </span>2004;<span class="ref-vol">23</span>:2423–9.</span> [<a href="/pmc/articles/PMC423294/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC423294</span></a>] [<a href="/pubmed/15167897" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15167897</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca-io.REF.koskinen.1995a.263">Koskinen T, Pihko H, Voutilainen R. Primary hypogonadism in females with infantile onset spinocerebellar ataxia. <span><span class="ref-journal">Neuropediatrics. </span>1995a;<span class="ref-vol">26</span>:263–6.</span> [<a href="/pubmed/8552218" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8552218</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca-io.REF.koskinen.1994a.509">Koskinen T, Sainio K, Rapola J, Pihko H, Paetau A. Sensory neuropathy in infantile onset spinocerebellar ataxia (IOSCA). <span><span class="ref-journal">Muscle Nerve. </span>1994a;<span class="ref-vol">17</span>:509–15.</span> [<a href="/pubmed/8159181" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8159181</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca-io.REF.koskinen.1994b.50">Koskinen T, Santavuori P, Sainio K, Lappi M, Kallio AK, Pihko H. Infantile onset spinocerebellar ataxia with sensory neuropathy: a new inherited disease. <span><span class="ref-journal">J Neurol Sci. </span>1994b;<span class="ref-vol">121</span>:50–6.</span> [<a href="/pubmed/8133312" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8133312</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca-io.REF.koskinen.1995b.1427">Koskinen T, Valanne L, Ketonen LM, Pihko H. Infantile-onset spinocerebellar ataxia: MR and CT findings. <span><span class="ref-journal">AJNR Am J Neuroradiol. </span>1995b;<span class="ref-vol">16</span>:1427–33.</span> [<a href="/pubmed/7484627" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7484627</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca-io.REF.l_nnqvist.1998.57">L&#x000f6;nnqvist T, Paetau A, Nikali K, von Boguslawski K, Pihko H. Infantile onset spinocerebellar ataxia with sensory neuropathy (IOSCA): neuropathological features. <span><span class="ref-journal">J Neurol Sci. </span>1998;<span class="ref-vol">161</span>:57–65.</span> [<a href="/pubmed/9879682" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9879682</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca-io.REF.l_nnqvist.2009.1553">L&#x000f6;nnqvist T, Paetau A, Valanne L, Pihko H. Recessive Twinkle mutations cause severe epileptic encephalopathy. <span><span class="ref-journal">Brain. </span>2009;<span class="ref-vol">132</span>:1553–62.</span> [<a href="/pubmed/19304794" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19304794</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca-io.REF.matsushima.2008.23964">Matsushima Y, Farr CL, Fan L, Kaguni LS. Physiological and biochemical defects in carboxyl-terminal mutants of mitochondrial DNA helicase. <span><span class="ref-journal">J Biol Chem. </span>2008;<span class="ref-vol">283</span>:23964–71.</span> [<a href="/pmc/articles/PMC2527111/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2527111</span></a>] [<a href="/pubmed/18593709" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18593709</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca-io.REF.nikali.2005.2981">Nikali K, Suomalainen A, Saharinen J, Kuokkanen M, Spelbrink JN, L&#x000f6;nnqvist T, Peltonen L. Infantile onset spinocerebellar ataxia is caused by recessive mutations in mitochondrial proteins Twinkle and Twinky. <span><span class="ref-journal">Hum Mol Genet. </span>2005;<span class="ref-vol">14</span>:2981–90.</span> [<a href="/pubmed/16135556" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16135556</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca-io.REF.park.2014.171">Park MH, Woo HM, Hong YB, Park JH, Yoon BR, Park JM, Yoo JH, Koo H, Chae JH, Chung KW, Choi BO, Koo SK. Recessive C10orf2 mutations in a family with infantile-onset spinocerebellar ataxia, sensorimotor polyneuropathy, and myopathy. <span><span class="ref-journal">Neurogenetics. </span>2014;<span class="ref-vol">15</span>:171–82.</span> [<a href="/pmc/articles/PMC4102772/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4102772</span></a>] [<a href="/pubmed/24816431" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24816431</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca-io.REF.pierce.2016.a001107">Pierce SB, Gulsuner S, Stapleton GA, Walsh T, Lee MK, Mandell JB, Morales A, Klevit RE, King MC, Rogers RC. Infantile onset spinocerebellar ataxia caused by compound heterozygosity for Twinkle mutations and modeling of Twinkle mutations causing recessive disease. <span><span class="ref-journal">Cold Spring Harb Mol Case Stud. </span>2016;<span class="ref-vol">2</span>:a001107.</span> [<a href="/pmc/articles/PMC4990813/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4990813</span></a>] [<a href="/pubmed/27551684" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27551684</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca-io.REF.prasad.2013.190">Prasad C, Melan&#x000e7;on SB, Rupar CA, Prasad AN, Nunez LD, Rosenblatt DS, Majewski J. Exome sequencing reveals a homozygous mutation in TWINKLE as the cause of multisystemic failure including renal tubulopathy in three siblings. <span><span class="ref-journal">Mol Genet Metab. </span>2013;<span class="ref-vol">108</span>:190–4.</span> [<a href="/pubmed/23375728" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23375728</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca-io.REF.sarzi.2007.579">Sarzi E, Goffart S, Serre V, Chr&#x000e9;tien D, Slama A, Munnich A, Spelbrink JN, R&#x000f6;tig A. Twinkle helicase (PEO1) gene mutation causes mitochondrial DNA depletion. <span><span class="ref-journal">Ann Neurol. </span>2007;<span class="ref-vol">62</span>:579–87.</span> [<a href="/pubmed/17722119" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17722119</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca-io.REF.shutt.2006.588">Shutt TE, Gray MW. Twinkle, the mitochondrial replicative DNA helicase, is widespread in the eukaryotic radiation and may also be the mitochondrial DNA primase in most eukaryotes. <span><span class="ref-journal">J Mol Evol. </span>2006;<span class="ref-vol">62</span>:588–99.</span> [<a href="/pubmed/16612544" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16612544</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca-io.REF.spelbrink.2001.223">Spelbrink JN, Li FY, Tiranti V, Nikali K, Yuan QP, Tariq M, Wanrooij S, Garrido N, Comi G, Morandi L, Santoro L, Toscano A, Fabrizi GM, Somer H, Croxen R, Beeson D, Poulton J, Suomalainen A, Jacobs HT, Zeviani M, Larsson C. Human mitochondrial DNA deletions associated with mutations in the gene encoding Twinkle, a phage T7 gene 4-like protein localized in mitochondria. <span><span class="ref-journal">Nat Genet. </span>2001;<span class="ref-vol">28</span>:223–31.</span> [<a href="/pubmed/11431692" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11431692</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca-io.REF.suomalainen.1992.61">Suomalainen A, Majander A, Haltia M, Somer H, L&#x000f6;nnqvist J, Savontaus ML, Peltonen L. Multiple deletions of mitochondrial DNA in several tissues of a patient with severe retarded depression and familial progressive external ophthalmoplegia. <span><span class="ref-journal">J Clin Invest. </span>1992;<span class="ref-vol">90</span>:61–6.</span> [<a href="/pmc/articles/PMC443063/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC443063</span></a>] [<a href="/pubmed/1634620" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1634620</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca-io.REF.tyynismaa.2004.3219">Tyynismaa H, Sembongi H, Bokori-Brown M, Granycome C, Ashley N, Poulton J, Jalanko A, Spelbrink JN, Holt IJ, Suomalainen A. Twinkle helicase is essential for mtDNA maintenance and regulates mtDNA copy number. <span><span class="ref-journal">Hum Mol Genet. </span>2004;<span class="ref-vol">13</span>:3219–27.</span> [<a href="/pubmed/15509589" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15509589</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca-io.REF.wanrooij.2008.11122">Wanrooij S, Fust&#x000e9; JM, Farge G, Shi Y, Gustafsson CM, Falkenberg M. Human mitochondrial RNA polymerase primes lagging-strand DNA synthesis in vitro. <span><span class="ref-journal">Proc Natl Acad Sci USA. </span>2008;<span class="ref-vol">105</span>:11122–7.</span> [<a href="/pmc/articles/PMC2516254/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2516254</span></a>] [<a href="/pubmed/18685103" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18685103</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca-io.REF.zeviani.1989.309">Zeviani M, Servidei S, Gellera C, Bertini E, DiMauro S, DiDonato S. An autosomal dominant disorder with multiple deletions of mitochondrial DNA starting at the D-loop region. <span><span class="ref-journal">Nature. </span>1989;<span class="ref-vol">339</span>:309–11.</span> [<a href="/pubmed/2725645" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2725645</span></a>]</div></li></ul></div></div><div id="sca-io.Chapter_Notes"><h2 id="_sca-io_Chapter_Notes_">Chapter Notes</h2><div id="sca-io.Author_History"><h3>Author History</h3><p>Tuula L&#x000f6;nnqvist, MD, PhD (2009-present)<br />Kaisu Nikali, MD, PhD; University College London (2009-2018)</p></div><div id="sca-io.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>19 April 2018 (ma) Comprehensive update posted live</div></li><li class="half_rhythm"><div>15 January 2015 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>22 July 2010 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>27 January 2009 (me) Review posted live</div></li><li class="half_rhythm"><div>17 September 2008 (kn) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK3795</span><span class="label">PMID: <a href="/pubmed/20301746" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301746</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/i-p/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/kms/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK3795&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK3795/?report=reader">PubReader</a></li><li><a href="/books/NBK3795/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK3795" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK3795" style="display:none" title="Cite this Page"><div class="bk_tt">Lönnqvist T. Infantile-Onset Spinocerebellar Ataxia. 2009 Jan 27 [Updated 2018 Apr 19]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK3795/pdf/Bookshelf_NBK3795.pdf">PDF version of this page</a> (445K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#sca-io.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#sca-io.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#sca-io.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#sca-io.Genetically_Related_Allelic_Disor" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#sca-io.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#sca-io.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#sca-io.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#sca-io.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#sca-io.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#sca-io.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#sca-io.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=56652[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">TWNK</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Variations in ClinVar</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NBK3795+AND+genereviews[submitter]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Variations from this GeneReview in ClinVar</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1463624" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1463624" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1463624" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1463624" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301791" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">POLG</i>-Related Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">POLG</i>-Related Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Cohen BH, Chinnery PF, Copeland WC. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/25719194" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">TBC1D24</i>-Related Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">TBC1D24</i>-Related Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Mucha BE, Hennekam RCM, Sisodiya S, Campeau PM. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301659" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Pyridoxine-Dependent Epilepsy</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Pyridoxine-Dependent Epilepsy<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Gospe SM Jr. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/25254289" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Perrault Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Perrault Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Newman WG, Friedman TB, Conway GS, Demain LAM. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301750" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">WFS1</i>-Related Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">WFS1</i>-Related Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Tranebjærg L, Barrett T, Rendtorff ND. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301746" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301746" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5dfc90addde089116950289a">Infantile-Onset Spinocerebellar Ataxia - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Infantile-Onset Spinocerebellar Ataxia - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-20T04:13:17-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal103&amp;ncbi_phid=CE8AADB0DFC843010000000005F302C9&amp;ncbi_session=CE8AADB0DFC90AC1_1523SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK3795%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK3795&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK3795/&amp;ncbi_pagename=Infantile-Onset Spinocerebellar Ataxia - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8AADB0DFC90AC1_1523SID /projects/books/PBooks@5.22 portal103 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>